 LONDON and REDWOOD CITY, Calif., Feb. 18, 2021 GLOBE NEWSWIRE -- Mereo BioPharma Group plc NASDAQ: MREO Mereo or the Company, a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 8:00am Eastern Time. 